128 related articles for article (PubMed ID: 38084867)
1. Effect of baricitinib in patients with alopecia areata: Usefulness of trichoscopic evaluation.
Diluvio L; Matteini E; Lambiase S; Cioni A; Gaeta Shumak R; Dattola A; Bianchi L; Campione E
J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):e478-e480. PubMed ID: 38084867
[No Abstract] [Full Text] [Related]
2. Baricitinib in Alopecia Areata.
Messenger A; Harries M
N Engl J Med; 2022 May; 386(18):1751-1752. PubMed ID: 35507486
[No Abstract] [Full Text] [Related]
3. Oral Baricitinib Restores Hair Loss in Alopecia Areata.
Slomski A
JAMA; 2022 Jun; 327(24):2386. PubMed ID: 35762995
[No Abstract] [Full Text] [Related]
4. Subclinical, early hair regrowth in alopecia areata patients under treatment with baricitinib detected by line-field confocal optical coherence tomography evaluation.
Verzì AE; Lacarrubba F; Dall'Oglio F; Rini S; Tosti A; Micali G
J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):e459-e461. PubMed ID: 37909307
[No Abstract] [Full Text] [Related]
5. Baricitinib for the treatment of alopecia areata in adults: Real-world analysis of 36 patients.
Moreno-Vílchez C; Bonfill-Ortí M; Bauer-Alonso A; Notario J; Figueras-Nart I
J Am Acad Dermatol; 2024 May; 90(5):1059-1061. PubMed ID: 38246562
[No Abstract] [Full Text] [Related]
6. Baricitinib improved alopecia areata concomitant with atopic dermatitis: A case report.
Uchida H; Kamata M; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol; 2021 Sep; 48(9):e472-e473. PubMed ID: 34151450
[No Abstract] [Full Text] [Related]
7. Two Phase 3 Trials of Baricitinib for Alopecia Areata.
King B; Ohyama M; Kwon O; Zlotogorski A; Ko J; Mesinkovska NA; Hordinsky M; Dutronc Y; Wu WS; McCollam J; Chiasserini C; Yu G; Stanley S; Holzwarth K; DeLozier AM; Sinclair R;
N Engl J Med; 2022 May; 386(18):1687-1699. PubMed ID: 35334197
[TBL] [Abstract][Full Text] [Related]
8. Alopecia areata treatment with baricitinib: different relapse phenotypes.
Dall'Oglio F; Nasca MR; Lacarrubba F; Vitale P; Micali G
J Dermatolog Treat; 2024 Dec; 35(1):2324832. PubMed ID: 38465657
[No Abstract] [Full Text] [Related]
9. Complete response of extensive alopecia areata refractory to baricitinib after five months of treatment with upadacitinib.
De la Torre-Gomar FJ; Velasco-Amador JP; Prados-Carmona Á; Ruiz-Villaverde R
J Dermatolog Treat; 2024 Dec; 35(1):2304630. PubMed ID: 38240097
[No Abstract] [Full Text] [Related]
10. Atopic dermatitis and multilocular alopecia areata simultaneously treated with baricitinib.
Pestana M; Brito Caldeira M; Duarte B
Actas Dermosifiliogr; 2024 Feb; 115(2):T200-T201. PubMed ID: 37952837
[No Abstract] [Full Text] [Related]
11. Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib.
Pestana M; Brito Caldeira M; Duarte B
Actas Dermosifiliogr; 2024 Feb; 115(2):200-201. PubMed ID: 36842474
[No Abstract] [Full Text] [Related]
12. Baricitinib Therapy for Moderate to Severe Alopecia Areata: A Retrospective Review of 95 Japanese Patients.
Numata T; Irisawa R; Mori M; Uchiyama M; Harada K
Acta Derm Venereol; 2024 Jan; 104():adv18348. PubMed ID: 38248913
[No Abstract] [Full Text] [Related]
13. Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children.
Fang H; Zhang F; Lin W; Jiang Y; Liu Q; Yang D
Front Immunol; 2024; 15():1395288. PubMed ID: 38903518
[TBL] [Abstract][Full Text] [Related]
14. Treatment of alopecia areata of the beard with baricitinib.
Moussa A; Eisman S; Sinclair RD; Bhoyrul B
J Am Acad Dermatol; 2023 Apr; 88(4):948-950. PubMed ID: 36427662
[No Abstract] [Full Text] [Related]
15. Baricitinib (Olumiant) for the Treatment of Alopecia Areata.
Pheasant L
Am Fam Physician; 2023 Nov; 108(5):513-514. PubMed ID: 37983706
[No Abstract] [Full Text] [Related]
16. The Good and Bad News About New Drugs for Treating Alopecia Areata.
Morgado-Carrasco D; Rodríguez-Lobato E; Riera-Monroig J; Ferrando J
Actas Dermosifiliogr (Engl Ed); 2018; 109(1):69-70. PubMed ID: 28641742
[No Abstract] [Full Text] [Related]
17. Baricitinib (Olumiant) for severe alopecia areata.
Med Lett Drugs Ther; 2022 Sep; 64(1658):139-141. PubMed ID: 36094552
[No Abstract] [Full Text] [Related]
18. Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience.
Gargiulo L; Ibba L; Vignoli CA; Ferrucci SM; Mercuri SR; Malagoli P; Marzano AV; Barbareschi M; Bianchi VG; Valenti M; Costanzo A; Narcisi A
J Dermatolog Treat; 2023 Dec; 34(1):2268764. PubMed ID: 37818648
[No Abstract] [Full Text] [Related]
19. Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata.
Chen D; Huang W; Zhongjie W; Feifeng R; Luo L; Jun Z; Dongmei H; Tian M; Tang L
Rheumatology (Oxford); 2022 Aug; 61(8):e221-e223. PubMed ID: 35148369
[No Abstract] [Full Text] [Related]
20. Effectiveness and safety of baricitinib in patients with moderate-to-severe refractory alopecia areata in real world: An open-label, single-center study.
Bi L; Wang C; Du Y; Su T; Zhao M; Lin X; Fan W; Sun W
J Cosmet Dermatol; 2024 Apr; 23(4):1417-1421. PubMed ID: 38116864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
